Literature DB >> 9274897

Hypercalcemia of malignancy.

G R Mundy1, T A Guise.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9274897     DOI： 10.1016/s0002-9343(97)80047-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  21 in total

1.  Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone.

Authors:  Olga Zolochevska; Jayne Ellis; Sangram Parelkar; Delphine Chan-Seng; Todd Emrick; Jingna Wei; Igor Patrikeev; Massoud Motamedi; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2013-11-06       Impact factor: 5.695

2.  TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.

Authors:  Rachelle W Johnson; Mai P Nguyen; Susan S Padalecki; Barry G Grubbs; Alyssa R Merkel; Babatunde O Oyajobi; Lynn M Matrisian; Gregory R Mundy; Julie A Sterling
Journal:  Cancer Res       Date:  2010-12-28       Impact factor: 12.701

3.  54-year-old woman with fatigue, back pain, and hypercalcemia.

Authors:  D Brian Newman; Jamie J Kearns; Thomas J Beckman
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

4.  Physicians' attitude toward recurrent hypercalcemia in terminally ill cancer patients.

Authors:  Akira Shimada; Ichiro Mori; Isseki Maeda; Hidekazu Watanabe; Nobutaka Kikuchi; Hansheng Ding; Tatsuya Morita
Journal:  Support Care Cancer       Date:  2014-07-22       Impact factor: 3.603

5.  Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

Authors:  V Belardi; E Fiore; E Giustarini; I Muller; S Sabatini; V Rosellini; E Seregni; R Agresti; C Marcocci; P Vitti; C Giani
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

Review 6.  Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Authors:  N Zojer; A V Keck; M Pecherstorfer
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

7.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

8.  Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia.

Authors:  Katy Wong; Shawn Tsuda; Ryan Mukai; Kenneth Sumida; Richard Arakaki
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

Review 9.  Paraneoplastic endocrine syndromes: a review.

Authors:  Ronald A DeLellis; Ling Xia
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  AU-rich elements in the 3'-UTR regulate the stability of the 141 amino acid isoform of parathyroid hormone-related protein mRNA.

Authors:  Alexander I Luchin; Murali V P Nadella; Nanda K Thudi; Wessel P Dirksen; Parul Gulati; Soledad A Fernandez; Thomas J Rosol
Journal:  Mol Cell Endocrinol       Date:  2012-08-31       Impact factor: 4.102
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.